0001477449-24-000002.txt : 20240104
0001477449-24-000002.hdr.sgml : 20240104
20240104160531
ACCESSION NUMBER: 0001477449-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nanis Nikolaos P.
CENTRAL INDEX KEY: 0002001935
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 24511808
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
wk-form4_1704402309.xml
FORM 4
X0508
4
2024-01-02
0
0001477449
Teladoc Health, Inc.
TDOC
0002001935
Nanis Nikolaos P.
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
Chief Technology Officer
0
Common Stock
2024-01-02
4
M
0
1232
A
65551
D
Common Stock
2024-01-03
4
S
0
520
21.359
D
65031
D
Restricted Stock Units
2024-01-02
4
M
0
1232
0
D
Common Stock
1232
8630
D
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2024-01-04